FIRST CLICK HERE AND READ OUR OVERVIEW
The Institute of Cancer Research is mounting a 500 strong BRCA1 and BRCA2 screening study for men across Europe. A BRCA1 mutation in men is linked to a five-fold increased risk of prostate cancer, whilst BRCA2 is about half this risk. One aim is to try to identify those men with the highest risk of an aggressive cancer.